Celltrion

글로벌 헬스케어의 새로운 장을 열어갑니다

Our beginning was humble.
We started with a dream.
A dream to benefit patients with affordable drugs.

While the other Korean pharmaceutical companies focused on the domestic market, we looked out into the world.
We saw an opportunity in the biosimilar market.
By investing almost half of our earnings to R&D, we succeeded in gaining approval in the strict biosimilar space.

We created and led the world’s first “antibody biosimilar market,” a market that even the world’s multinational pharmaceutical giants could not dream of starting.

Now, Celltrion ventures toward the world,
to become a global leader and lead the future of Korea’s biopharmaceutical industry.

We are here thanks to the efforts of many.
We will remember all those who helped us get where we are today,
and continue our efforts to contribute to society, the world, and humankind through our business.

Thank you.

Jungjin Seo, Honorary Chairman, Celltrion Group

We aspire to build a future of coexistence that promises happiness for all.

Celltrion developed the world’s first antibody biosimilar “Remsima,” an achievement that shifted the paradigm of the global biopharmaceutical market previously dominated by a handful of multinational pharmaceutical giants and paved the way for the growth of the Korean pharmaceutical sector.

Over the years, many players in and outside of Korea have entered the biopharmaceutical market.
However, the path had been largely untrodden when Celltrion first sought to tread on it because of the massive capital and technical resources required and the slim chance of success. It was a lonely and challenging journey.

However, all of us at Celltrion shared a dream.

A dream to develop a biosimilar product to replace high-priced biopharmaceutical products for the benefit of patients across the world.
A dream to develop innovative new drugs and become a global biopharmaceutical leader.
We turned this dream into reality through thorough planning, deep conviction, and ceaseless efforts to overcome challenges.

We realized our dream by venturing into uncharted areas, and we will continue to tread our path toward the future.

We will do everything within our power to provide patients with more affordable and effective pharmaceutical products and promote health for all.

Your love and support will mean much to us in our journey to becoming a leading global biopharmaceutical company.

Thank you.

Woosung Kee CEO and Vice Chairman, Celltrion